Nuwellis (NUWE) Work In Process (2017 - 2026)

Nuwellis (NUWE) posted Work In Process of $138000.0 for Q1 2026, up 56.82% on a QoQ basis from $88000.0 in Q4 2025, and down 0.72% year-over-year from $139000.0 in Q1 2025.

Nuwellis (NUWE) Work In Process (2017 - 2026) Analysis & Trends

Nuwellis' Work In Process history runs 10 years deep, the most recent figure standing at $138000.0 for Q1 2026.

  • Quarterly Work In Process fell 0.72% year-over-year to $138000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $138000.0 (down 0.72% YoY) and the FY2025 annual result came in at $88000.0, down 32.82% from the prior year.
  • Work In Process was $138000.0 for Q1 2026 at Nuwellis, up from $88000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $425000.0 in Q2 2025 and bottomed at $88000.0 in Q4 2025.
  • A 5-year average of $213705.9 and a median of $204000.0 in 2022 frame the typical range for Work In Process.
  • Peak annual rise in Work In Process reached 59.88% in 2023, while the deepest fall reached 45.05% in 2023.
  • Nuwellis' Work In Process stood at $204000.0 in 2022, then gained by 1.47% to $207000.0 in 2023, then slumped by 36.71% to $131000.0 in 2024, then slumped by 32.82% to $88000.0 in 2025, then jumped by 56.82% to $138000.0 in 2026.
  • Business Quant data shows NUWE's Work In Process at $138000.0 in Q1 2026, $88000.0 in Q4 2025, and $251000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Nuwellis 613.80 -2.08 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 138,000.00
Dec 31, 2025 88,000.00
Sep 30, 2025 251,000.00
Jun 30, 2025 425,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 131,000.00
Sep 30, 2024 220,000.00
Jun 30, 2024 307,000.00
Mar 31, 2024 198,000.00
Dec 31, 2023 207,000.00
Sep 30, 2023 170,000.00
Jun 30, 2023 275,000.00
Mar 31, 2023 172,000.00
Dec 31, 2022 204,000.00
Sep 30, 2022 223,000.00
Jun 30, 2022 172,000.00
Mar 31, 2022 313,000.00
Dec 31, 2021 276,000.00
Sep 30, 2021 268,000.00
Jun 30, 2021 199,000.00